Rank | Gene Set | Z-score |
---|---|---|
1 | cardiac myofibril assembly (GO:0055003) | 7.58016005 |
2 | sarcomere organization (GO:0045214) | 7.57227242 |
3 | tricarboxylic acid cycle (GO:0006099) | 6.79588207 |
4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.76927900 |
5 | myofibril assembly (GO:0030239) | 6.58848693 |
6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.46883170 |
7 | * cardiac muscle contraction (GO:0060048) | 5.89054713 |
8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.87736356 |
9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.84562809 |
10 | actin-myosin filament sliding (GO:0033275) | 5.74773647 |
11 | muscle filament sliding (GO:0030049) | 5.74773647 |
12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.70106664 |
13 | plasma membrane repair (GO:0001778) | 5.69028040 |
14 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.54749084 |
15 | cardiac muscle cell development (GO:0055013) | 5.46601242 |
16 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.34723905 |
17 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.25158365 |
18 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.21414744 |
19 | carnitine shuttle (GO:0006853) | 5.16152836 |
20 | cardiac cell development (GO:0055006) | 5.12394442 |
21 | regulation of actin filament-based movement (GO:1903115) | 5.10203528 |
22 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.92721055 |
23 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.90211414 |
24 | ATP synthesis coupled proton transport (GO:0015986) | 4.90211414 |
25 | respiratory electron transport chain (GO:0022904) | 4.88579355 |
26 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.88262341 |
27 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.88123516 |
28 | adult heart development (GO:0007512) | 4.86008042 |
29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.83283751 |
30 | regulation of relaxation of muscle (GO:1901077) | 4.79947032 |
31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.76061473 |
32 | actomyosin structure organization (GO:0031032) | 4.75574695 |
33 | electron transport chain (GO:0022900) | 4.74956852 |
34 | oxidative phosphorylation (GO:0006119) | 4.69180269 |
35 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.67313505 |
36 | regulation of skeletal muscle contraction (GO:0014819) | 4.66107196 |
37 | heart trabecula formation (GO:0060347) | 4.64886905 |
38 | actin-mediated cell contraction (GO:0070252) | 4.59830360 |
39 | regulation of cofactor metabolic process (GO:0051193) | 4.59172949 |
40 | regulation of coenzyme metabolic process (GO:0051196) | 4.59172949 |
41 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.51826791 |
42 | NADH metabolic process (GO:0006734) | 4.50128706 |
43 | * striated muscle contraction (GO:0006941) | 4.48739832 |
44 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.48208698 |
45 | regulation of membrane repolarization (GO:0060306) | 4.47596875 |
46 | fatty acid transmembrane transport (GO:1902001) | 4.44296949 |
47 | cardiac muscle hypertrophy (GO:0003300) | 4.41873480 |
48 | adhesion of symbiont to host cell (GO:0044650) | 4.39485677 |
49 | virion attachment to host cell (GO:0019062) | 4.39485677 |
50 | regulation of cell communication by electrical coupling (GO:0010649) | 4.34214757 |
51 | regulation of the force of heart contraction (GO:0002026) | 4.33124735 |
52 | cell communication involved in cardiac conduction (GO:0086065) | 4.31037911 |
53 | cell communication by electrical coupling (GO:0010644) | 4.30290229 |
54 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.28460829 |
55 | adhesion of symbiont to host (GO:0044406) | 4.20350902 |
56 | striated muscle hypertrophy (GO:0014897) | 4.19552208 |
57 | regulation of striated muscle contraction (GO:0006942) | 4.18028870 |
58 | muscle tissue morphogenesis (GO:0060415) | 4.17670792 |
59 | heart process (GO:0003015) | 4.16128171 |
60 | heart contraction (GO:0060047) | 4.16128171 |
61 | low-density lipoprotein particle clearance (GO:0034383) | 4.04483667 |
62 | regulation of sequestering of triglyceride (GO:0010889) | 4.03090221 |
63 | regulation of sarcomere organization (GO:0060297) | 4.02653946 |
64 | 2-oxoglutarate metabolic process (GO:0006103) | 3.94563652 |
65 | regulation of fatty acid oxidation (GO:0046320) | 3.77471854 |
66 | carnitine transmembrane transport (GO:1902603) | 3.74957726 |
67 | regulation of early endosome to late endosome transport (GO:2000641) | 3.74792178 |
68 | muscle hypertrophy (GO:0014896) | 3.68009327 |
69 | barbed-end actin filament capping (GO:0051016) | 3.62941294 |
70 | succinate metabolic process (GO:0006105) | 3.62180542 |
71 | negative regulation of potassium ion transport (GO:0043267) | 3.61080661 |
72 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.60708728 |
73 | regulation of heart rate (GO:0002027) | 3.57149399 |
74 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.55732223 |
75 | regulation of sulfur metabolic process (GO:0042762) | 3.55166731 |
76 | activation of MAPKKK activity (GO:0000185) | 3.55045782 |
77 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.54416853 |
78 | cardiac muscle cell action potential (GO:0086001) | 3.52734945 |
79 | regulation of cardiac muscle contraction (GO:0055117) | 3.51127239 |
80 | oxaloacetate metabolic process (GO:0006107) | 3.50440938 |
81 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.47273796 |
82 | cell migration involved in heart development (GO:0060973) | 3.46634226 |
83 | amino-acid betaine transport (GO:0015838) | 3.45664628 |
84 | carnitine transport (GO:0015879) | 3.45664628 |
85 | creatine metabolic process (GO:0006600) | 3.42805156 |
86 | actin filament-based movement (GO:0030048) | 3.40010455 |
87 | regulation of heart contraction (GO:0008016) | 3.37733298 |
88 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.36769132 |
89 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.36426017 |
90 | fatty acid beta-oxidation (GO:0006635) | 3.35446330 |
91 | aspartate family amino acid catabolic process (GO:0009068) | 3.31672234 |
92 | ATP biosynthetic process (GO:0006754) | 3.29753196 |
93 | tricarboxylic acid metabolic process (GO:0072350) | 3.28999946 |
94 | regulation of ATPase activity (GO:0043462) | 3.28731792 |
95 | regulation of ATP catabolic process (GO:1903289) | 3.28731792 |
96 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.26480954 |
97 | oxygen transport (GO:0015671) | 3.26242236 |
98 | cardiac conduction (GO:0061337) | 3.24701903 |
99 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.23316554 |
100 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.23316554 |
101 | cardiac muscle adaptation (GO:0014887) | 3.21741270 |
102 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.21741270 |
103 | muscle hypertrophy in response to stress (GO:0003299) | 3.21741270 |
104 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.21206897 |
105 | lysine metabolic process (GO:0006553) | 3.19882234 |
106 | lysine catabolic process (GO:0006554) | 3.19882234 |
107 | relaxation of cardiac muscle (GO:0055119) | 3.19881104 |
108 | protein heterotrimerization (GO:0070208) | 3.17340211 |
109 | keratan sulfate catabolic process (GO:0042340) | 3.17195095 |
110 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.17077699 |
111 | striated muscle cell development (GO:0055002) | 3.13973500 |
112 | regulation of cholesterol storage (GO:0010885) | 3.10754336 |
113 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.07767651 |
114 | response to dietary excess (GO:0002021) | 3.00850562 |
115 | stress fiber assembly (GO:0043149) | 2.90556989 |
116 | endothelial cell chemotaxis (GO:0035767) | 2.90499551 |
117 | regulation of extracellular matrix disassembly (GO:0010715) | 2.90042079 |
118 | triglyceride catabolic process (GO:0019433) | 2.86205785 |
119 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.84999458 |
120 | astrocyte differentiation (GO:0048708) | 2.74889423 |
121 | positive regulation of protein dephosphorylation (GO:0035307) | 2.73900286 |
122 | acylglycerol catabolic process (GO:0046464) | 2.71441911 |
123 | neutral lipid catabolic process (GO:0046461) | 2.71441911 |
124 | apoptotic cell clearance (GO:0043277) | 2.69554719 |
125 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.66941574 |
126 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.66129703 |
127 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.65329391 |
128 | positive regulation of receptor recycling (GO:0001921) | 2.62734813 |
129 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.62405117 |
130 | venous blood vessel morphogenesis (GO:0048845) | 2.53384652 |
131 | extracellular fibril organization (GO:0043206) | 2.51935308 |
132 | chondroitin sulfate catabolic process (GO:0030207) | 2.51066994 |
133 | cellular response to epinephrine stimulus (GO:0071872) | 2.44787422 |
134 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.41499315 |
135 | lipid storage (GO:0019915) | 2.40297056 |
136 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.39293574 |
137 | cAMP biosynthetic process (GO:0006171) | 2.38339544 |
138 | basement membrane organization (GO:0071711) | 2.37190357 |
139 | protein retention in ER lumen (GO:0006621) | 2.37186567 |
140 | mannose metabolic process (GO:0006013) | 2.35390120 |
141 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.35283844 |
142 | tooth mineralization (GO:0034505) | 2.33409289 |
143 | positive regulation of lipid storage (GO:0010884) | 2.32824463 |
144 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.32593972 |
145 | response to parathyroid hormone (GO:0071107) | 2.30707293 |
146 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.29220993 |
147 | extracellular matrix assembly (GO:0085029) | 2.29175424 |
148 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.28878669 |
149 | UV protection (GO:0009650) | 2.28495201 |
150 | cellular response to catecholamine stimulus (GO:0071870) | 2.27617775 |
151 | cellular response to monoamine stimulus (GO:0071868) | 2.27617775 |
152 | protein localization to endosome (GO:0036010) | 2.27435091 |
153 | amino sugar catabolic process (GO:0046348) | 2.27396533 |
154 | response to acidic pH (GO:0010447) | 2.26611269 |
155 | glial cell migration (GO:0008347) | 2.26034909 |
156 | potassium ion export (GO:0071435) | 2.24737763 |
157 | glycerolipid catabolic process (GO:0046503) | 2.24456884 |
158 | activation of protein kinase A activity (GO:0034199) | 2.22403599 |
159 | fibril organization (GO:0097435) | 2.20773113 |
160 | cellular response to nutrient (GO:0031670) | 2.19495555 |
161 | * vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.18662527 |
162 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.17761219 |
163 | adenosine receptor signaling pathway (GO:0001973) | 2.16058948 |
164 | pattern specification involved in kidney development (GO:0061004) | 2.15992824 |
165 | skeletal muscle organ development (GO:0060538) | 2.15873557 |
166 | negative regulation of granulocyte differentiation (GO:0030853) | 2.15806721 |
167 | cortical actin cytoskeleton organization (GO:0030866) | 2.15074989 |
168 | protein maturation by protein folding (GO:0022417) | 2.14175308 |
169 | fatty acid homeostasis (GO:0055089) | 2.13845790 |
170 | gluconeogenesis (GO:0006094) | 2.13290111 |
171 | endocytic recycling (GO:0032456) | 2.12471544 |
172 | positive regulation of fat cell differentiation (GO:0045600) | 2.11468637 |
173 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.10843697 |
174 | positive regulation of extracellular matrix organization (GO:1903055) | 2.10557486 |
175 | macroautophagy (GO:0016236) | 2.09428616 |
176 | negative regulation of cell size (GO:0045792) | 2.09010437 |
177 | semaphorin-plexin signaling pathway (GO:0071526) | 2.08686597 |
178 | regulation of protein dephosphorylation (GO:0035304) | 2.08597257 |
179 | cell-cell junction maintenance (GO:0045217) | 2.08506165 |
180 | apoptotic process involved in morphogenesis (GO:0060561) | 2.08023048 |
181 | skin morphogenesis (GO:0043589) | 2.07699982 |
182 | negative regulation of focal adhesion assembly (GO:0051895) | 2.07482793 |
183 | negative regulation of cell junction assembly (GO:1901889) | 2.07482793 |
184 | negative regulation of adherens junction organization (GO:1903392) | 2.07482793 |
185 | response to epinephrine (GO:0071871) | 2.07187008 |
186 | regulation of autophagic vacuole assembly (GO:2000785) | 2.06969919 |
187 | adherens junction assembly (GO:0034333) | 2.06215812 |
188 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.06117183 |
189 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.06086463 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.39893075 |
2 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.84861620 |
3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.08296469 |
4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.07560651 |
5 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.01459434 |
6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.96161832 |
7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.96161832 |
8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.92133701 |
9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.63642771 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.45355691 |
11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32099473 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.25737823 |
13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.25070289 |
14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.17180175 |
15 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.11048463 |
16 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.09470912 |
17 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.08276889 |
18 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.03475780 |
19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.98323443 |
20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.94176058 |
21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.93365454 |
22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92860107 |
23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84236719 |
24 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.80366712 |
25 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.76975609 |
26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.70449948 |
27 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.65471333 |
28 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.62063029 |
29 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.59203161 |
30 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.58850624 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56884144 |
32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48761044 |
33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48643051 |
34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47962170 |
35 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46843423 |
36 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.46642430 |
37 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.44104979 |
38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43905524 |
39 | P68_20966046_ChIP-Seq_HELA_Human | 1.43716817 |
40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40648667 |
41 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.39723107 |
42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38504980 |
43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37903731 |
44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36356345 |
45 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36162132 |
46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34500269 |
47 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.34476020 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32795174 |
49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32644304 |
50 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.31798240 |
51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29438169 |
52 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29305020 |
53 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.28547173 |
54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28375645 |
55 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.27399110 |
56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27326865 |
57 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27099040 |
58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26346004 |
59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25673814 |
60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23818426 |
61 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.22994211 |
62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22321889 |
63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21633513 |
64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20149809 |
65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20058143 |
66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19563750 |
67 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.19241351 |
68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18433634 |
69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17446279 |
70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17092089 |
71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17078474 |
72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15700375 |
73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15037624 |
74 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14367755 |
75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14073390 |
76 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.13578110 |
77 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12864656 |
78 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12296703 |
79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11959255 |
80 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.11952012 |
81 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.11526958 |
82 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.11239118 |
83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10831755 |
84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10591813 |
85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07937718 |
86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07892548 |
87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07519217 |
88 | MYC_22102868_ChIP-Seq_BL_Human | 1.07310240 |
89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06911484 |
90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06524273 |
91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06280723 |
92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05614226 |
93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05357394 |
94 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05033697 |
95 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04991763 |
96 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04765262 |
97 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.04416788 |
98 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.04416788 |
99 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04222589 |
100 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03747783 |
101 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03502109 |
102 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03203987 |
103 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.03050391 |
104 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02256119 |
105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00893025 |
106 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00362813 |
107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.99692085 |
108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99515004 |
109 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99511647 |
110 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.98136105 |
111 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97927493 |
112 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97854795 |
113 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97812402 |
114 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.97361065 |
115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97273027 |
116 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96715812 |
117 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96554758 |
118 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.94228984 |
119 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94198857 |
120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93705384 |
121 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93207548 |
122 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92155843 |
123 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91924878 |
124 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91762199 |
125 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.91577166 |
126 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90926031 |
127 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90698829 |
128 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90204056 |
129 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89560146 |
130 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.88808500 |
131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88427503 |
132 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88190414 |
133 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87669489 |
134 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87625159 |
135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87386733 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.35143528 |
2 | MP0003646_muscle_fatigue | 5.64982705 |
3 | MP0000751_myopathy | 5.06976329 |
4 | MP0004084_abnormal_cardiac_muscle | 5.06160390 |
5 | MP0004215_abnormal_myocardial_fiber | 4.35137076 |
6 | MP0004036_abnormal_muscle_relaxation | 3.78043836 |
7 | MP0005330_cardiomyopathy | 3.71196587 |
8 | MP0000749_muscle_degeneration | 3.66443537 |
9 | MP0005058_abnormal_lysosome_morphology | 3.48218736 |
10 | MP0004087_abnormal_muscle_fiber | 3.03441101 |
11 | MP0004130_abnormal_muscle_cell | 3.00784731 |
12 | MP0005503_abnormal_tendon_morphology | 2.90699687 |
13 | MP0002972_abnormal_cardiac_muscle | 2.88440136 |
14 | MP0008775_abnormal_heart_ventricle | 2.80937248 |
15 | MP0000750_abnormal_muscle_regeneration | 2.77041661 |
16 | * MP0003137_abnormal_impulse_conducting | 2.72270914 |
17 | MP0005620_abnormal_muscle_contractility | 2.52231158 |
18 | MP0009840_abnormal_foam_cell | 2.51124602 |
19 | MP0002106_abnormal_muscle_physiology | 2.49060537 |
20 | MP0004145_abnormal_muscle_electrophysio | 2.48719116 |
21 | MP0010630_abnormal_cardiac_muscle | 2.48077702 |
22 | * MP0005385_cardiovascular_system_phenoty | 2.44249406 |
23 | * MP0001544_abnormal_cardiovascular_syste | 2.44249406 |
24 | MP0002269_muscular_atrophy | 2.35041562 |
25 | MP0004233_abnormal_muscle_weight | 2.33281165 |
26 | MP0001958_emphysema | 2.33013132 |
27 | MP0004484_altered_response_of | 2.32838286 |
28 | MP0006138_congestive_heart_failure | 2.32313069 |
29 | MP0005257_abnormal_intraocular_pressure | 2.20247139 |
30 | MP0003828_pulmonary_edema | 2.07812205 |
31 | MP0000759_abnormal_skeletal_muscle | 2.06580161 |
32 | MP0005369_muscle_phenotype | 2.04163964 |
33 | MP0006036_abnormal_mitochondrial_physio | 2.02908308 |
34 | MP0000747_muscle_weakness | 2.00611729 |
35 | MP0004085_abnormal_heartbeat | 1.99367783 |
36 | MP0005670_abnormal_white_adipose | 1.99167243 |
37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.94211953 |
38 | MP0005666_abnormal_adipose_tissue | 1.86837326 |
39 | MP0003879_abnormal_hair_cell | 1.70910057 |
40 | MP0002332_abnormal_exercise_endurance | 1.59623153 |
41 | MP0003172_abnormal_lysosome_physiology | 1.57916450 |
42 | MP0005451_abnormal_body_composition | 1.52199545 |
43 | MP0004185_abnormal_adipocyte_glucose | 1.47920262 |
44 | MP0002127_abnormal_cardiovascular_syste | 1.47046879 |
45 | MP0009384_cardiac_valve_regurgitation | 1.46973311 |
46 | MP0003329_amyloid_beta_deposits | 1.44529242 |
47 | MP0005375_adipose_tissue_phenotype | 1.36791025 |
48 | MP0003567_abnormal_fetal_cardiomyocyte | 1.35838754 |
49 | MP0005508_abnormal_skeleton_morphology | 1.30735036 |
50 | MP0003690_abnormal_glial_cell | 1.29187678 |
51 | MP0005409_darkened_coat_color | 1.28197771 |
52 | MP0002295_abnormal_pulmonary_circulatio | 1.25979278 |
53 | MP0004510_myositis | 1.25034627 |
54 | MP0000604_amyloidosis | 1.23997424 |
55 | MP0003634_abnormal_glial_cell | 1.17471155 |
56 | MP0003191_abnormal_cellular_cholesterol | 1.14684425 |
57 | * MP0000266_abnormal_heart_morphology | 1.13286699 |
58 | MP0001542_abnormal_bone_strength | 1.11623862 |
59 | MP0004043_abnormal_pH_regulation | 1.11256560 |
60 | MP0002234_abnormal_pharynx_morphology | 1.10888481 |
61 | MP0002909_abnormal_adrenal_gland | 1.09623193 |
62 | MP0003705_abnormal_hypodermis_morpholog | 1.09530954 |
63 | MP0003075_altered_response_to | 1.09446468 |
64 | MP0000013_abnormal_adipose_tissue | 1.08264966 |
65 | MP0009379_abnormal_foot_pigmentation | 1.05653619 |
66 | MP0002896_abnormal_bone_mineralization | 1.02698430 |
67 | MP0006035_abnormal_mitochondrial_morpho | 1.02407047 |
68 | MP0000003_abnormal_adipose_tissue | 1.02234696 |
69 | MP0002249_abnormal_larynx_morphology | 1.00510655 |
70 | MP0003279_aneurysm | 0.98658875 |
71 | MP0003303_peritoneal_inflammation | 0.98249492 |
72 | MP0003453_abnormal_keratinocyte_physiol | 0.98200496 |
73 | MP0001502_abnormal_circadian_rhythm | 0.96461831 |
74 | MP0005623_abnormal_meninges_morphology | 0.96263762 |
75 | MP0005165_increased_susceptibility_to | 0.95943348 |
76 | MP0002998_abnormal_bone_remodeling | 0.95806979 |
77 | MP0000858_altered_metastatic_potential | 0.95628867 |
78 | MP0005171_absent_coat_pigmentation | 0.95334020 |
79 | MP0003091_abnormal_cell_migration | 0.93679065 |
80 | MP0002933_joint_inflammation | 0.92515056 |
81 | MP0002108_abnormal_muscle_morphology | 0.92135644 |
82 | MP0005266_abnormal_metabolism | 0.92111442 |
83 | MP0000681_abnormal_thyroid_gland | 0.90912881 |
84 | MP0002638_abnormal_pupillary_reflex | 0.88893775 |
85 | MP0002971_abnormal_brown_adipose | 0.87215410 |
86 | MP0008961_abnormal_basal_metabolism | 0.86847439 |
87 | MP0001849_ear_inflammation | 0.83231485 |
88 | MP0009780_abnormal_chondrocyte_physiolo | 0.81885571 |
89 | * MP0000343_altered_response_to | 0.80274976 |
90 | MP0005023_abnormal_wound_healing | 0.79709084 |
91 | MP0003950_abnormal_plasma_membrane | 0.78755524 |
92 | MP0000230_abnormal_systemic_arterial | 0.78492031 |
93 | MP0005390_skeleton_phenotype | 0.78365905 |
94 | MP0003011_delayed_dark_adaptation | 0.77119886 |
95 | MP0003186_abnormal_redox_activity | 0.75796662 |
96 | MP0000920_abnormal_myelination | 0.75741506 |
97 | MP0005379_endocrine/exocrine_gland_phen | 0.72156144 |
98 | MP0000678_abnormal_parathyroid_gland | 0.71799641 |
99 | MP0002060_abnormal_skin_morphology | 0.70170043 |
100 | MP0004858_abnormal_nervous_system | 0.68612890 |
101 | MP0002128_abnormal_blood_circulation | 0.68536351 |
102 | MP0005535_abnormal_body_temperature | 0.68486261 |
103 | MP0003283_abnormal_digestive_organ | 0.68402944 |
104 | MP0003300_gastrointestinal_ulcer | 0.67796207 |
105 | MP0002078_abnormal_glucose_homeostasis | 0.66408160 |
106 | MP0010368_abnormal_lymphatic_system | 0.65696392 |
107 | MP0008438_abnormal_cutaneous_collagen | 0.64786152 |
108 | MP0000733_abnormal_muscle_development | 0.61720007 |
109 | MP0003566_abnormal_cell_adhesion | 0.56154774 |
110 | MP0004272_abnormal_basement_membrane | 0.48948371 |
111 | MP0005334_abnormal_fat_pad | 0.48804169 |
112 | MP0009115_abnormal_fat_cell | 0.48426742 |
113 | MP0002970_abnormal_white_adipose | 0.48059395 |
114 | MP0002877_abnormal_melanocyte_morpholog | 0.47366917 |
115 | MP0005319_abnormal_enzyme/_coenzyme | 0.46732518 |
116 | MP0008569_lethality_at_weaning | 0.45202760 |
117 | MP0003948_abnormal_gas_homeostasis | 0.43549999 |
118 | MP0004924_abnormal_behavior | 0.42353401 |
119 | MP0005386_behavior/neurological_phenoty | 0.42353401 |
120 | MP0002822_catalepsy | 0.41681542 |
121 | * MP0002925_abnormal_cardiovascular_devel | 0.41134780 |
122 | MP0004859_abnormal_synaptic_plasticity | 0.40755709 |
123 | MP0010030_abnormal_orbit_morphology | 0.40242760 |
124 | MP0001879_abnormal_lymphatic_vessel | 0.39478838 |
125 | MP0003984_embryonic_growth_retardation | 0.39471916 |
126 | MP0002088_abnormal_embryonic_growth/wei | 0.38831214 |
127 | MP0005452_abnormal_adipose_tissue | 0.37896302 |
128 | MP0001784_abnormal_fluid_regulation | 0.34733146 |
129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34024047 |
130 | MP0005275_abnormal_skin_tensile | 0.33453159 |
131 | MP0002118_abnormal_lipid_homeostasis | 0.32723653 |
132 | MP0005332_abnormal_amino_acid | 0.31874741 |
133 | MP0003959_abnormal_lean_body | 0.31261138 |
134 | MP0005167_abnormal_blood-brain_barrier | 0.29532525 |
135 | MP0005448_abnormal_energy_balance | 0.29374624 |
136 | MP0005595_abnormal_vascular_smooth | 0.27756768 |
137 | * MP0001614_abnormal_blood_vessel | 0.27723894 |
138 | MP0003122_maternal_imprinting | 0.26814392 |
139 | MP0000767_abnormal_smooth_muscle | 0.26059447 |
140 | MP0003953_abnormal_hormone_level | 0.24727847 |
141 | MP0009672_abnormal_birth_weight | 0.24640188 |
142 | MP0004147_increased_porphyrin_level | 0.23592176 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 7.04440532 |
2 | Ventricular tachycardia (HP:0004756) | 6.00911635 |
3 | Exercise-induced muscle cramps (HP:0003710) | 5.68750358 |
4 | Exercise-induced myalgia (HP:0003738) | 5.59834220 |
5 | Calf muscle hypertrophy (HP:0008981) | 5.51809645 |
6 | Atrial fibrillation (HP:0005110) | 5.34502978 |
7 | Myoglobinuria (HP:0002913) | 5.17098687 |
8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.07877743 |
9 | Primary atrial arrhythmia (HP:0001692) | 5.05955586 |
10 | Supraventricular tachycardia (HP:0004755) | 4.91317581 |
11 | Supraventricular arrhythmia (HP:0005115) | 4.81528762 |
12 | Muscle fiber splitting (HP:0003555) | 4.63993951 |
13 | Abnormality of the calf musculature (HP:0001430) | 4.62204852 |
14 | Lipoatrophy (HP:0100578) | 4.62189275 |
15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.55176891 |
16 | Subaortic stenosis (HP:0001682) | 4.55176891 |
17 | Bundle branch block (HP:0011710) | 4.49785717 |
18 | Protrusio acetabuli (HP:0003179) | 4.36369424 |
19 | Palpitations (HP:0001962) | 4.25800969 |
20 | Hyporeflexia of lower limbs (HP:0002600) | 4.19959082 |
21 | Asymmetric septal hypertrophy (HP:0001670) | 4.19195773 |
22 | Syncope (HP:0001279) | 4.07639884 |
23 | Abnormality of glycolipid metabolism (HP:0010969) | 4.05131063 |
24 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.05131063 |
25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.05131063 |
26 | Right ventricular cardiomyopathy (HP:0011663) | 4.02317565 |
27 | Prolonged QT interval (HP:0001657) | 3.98793339 |
28 | Vertebral compression fractures (HP:0002953) | 3.94431847 |
29 | Dilated cardiomyopathy (HP:0001644) | 3.84910365 |
30 | Rhabdomyolysis (HP:0003201) | 3.74268953 |
31 | EMG: myopathic abnormalities (HP:0003458) | 3.73577553 |
32 | Ventricular arrhythmia (HP:0004308) | 3.70749822 |
33 | Heart block (HP:0012722) | 3.64480071 |
34 | Ventricular fibrillation (HP:0001663) | 3.62575765 |
35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.59765298 |
36 | Acute necrotizing encephalopathy (HP:0006965) | 3.53549932 |
37 | Myotonia (HP:0002486) | 3.49878014 |
38 | Increased connective tissue (HP:0009025) | 3.48483202 |
39 | Abnormal atrioventricular conduction (HP:0005150) | 3.43474498 |
40 | Nuclear cataract (HP:0100018) | 3.42113951 |
41 | Difficulty running (HP:0009046) | 3.38732081 |
42 | Atrioventricular block (HP:0001678) | 3.36709082 |
43 | Hepatic necrosis (HP:0002605) | 3.32153838 |
44 | Axonal loss (HP:0003447) | 3.31011782 |
45 | Premature rupture of membranes (HP:0001788) | 3.28717913 |
46 | Acute encephalopathy (HP:0006846) | 3.24146150 |
47 | Ketoacidosis (HP:0001993) | 3.17915910 |
48 | Dysostosis multiplex (HP:0000943) | 3.13835491 |
49 | Abnormal EKG (HP:0003115) | 3.06173929 |
50 | Systemic lupus erythematosus (HP:0002725) | 2.92712966 |
51 | Progressive macrocephaly (HP:0004481) | 2.91810281 |
52 | Hepatocellular necrosis (HP:0001404) | 2.91208063 |
53 | Increased muscle lipid content (HP:0009058) | 2.89758476 |
54 | Spinal rigidity (HP:0003306) | 2.89341983 |
55 | Left ventricular hypertrophy (HP:0001712) | 2.82818451 |
56 | Mitochondrial inheritance (HP:0001427) | 2.82146041 |
57 | Cerebral aneurysm (HP:0004944) | 2.76049023 |
58 | Hypoglycemic coma (HP:0001325) | 2.71082205 |
59 | Muscle stiffness (HP:0003552) | 2.69483016 |
60 | Increased CSF lactate (HP:0002490) | 2.67812414 |
61 | Round ear (HP:0100830) | 2.65563274 |
62 | Difficulty climbing stairs (HP:0003551) | 2.65310560 |
63 | Retinal atrophy (HP:0001105) | 2.62836300 |
64 | Ragged-red muscle fibers (HP:0003200) | 2.61613485 |
65 | Conjunctival hamartoma (HP:0100780) | 2.58787699 |
66 | Neurofibrillary tangles (HP:0002185) | 2.57690265 |
67 | Pheochromocytoma (HP:0002666) | 2.57380356 |
68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.54133995 |
69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.54133995 |
70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.54133995 |
71 | Increased variability in muscle fiber diameter (HP:0003557) | 2.53781790 |
72 | Cerebral edema (HP:0002181) | 2.51801776 |
73 | Shallow orbits (HP:0000586) | 2.50241630 |
74 | Mucopolysacchariduria (HP:0008155) | 2.49753101 |
75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.49753101 |
76 | Testicular atrophy (HP:0000029) | 2.45816516 |
77 | Exercise intolerance (HP:0003546) | 2.45176876 |
78 | Achilles tendon contracture (HP:0001771) | 2.42473126 |
79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.41763469 |
80 | Dicarboxylic aciduria (HP:0003215) | 2.41763469 |
81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.38884963 |
82 | Obstructive sleep apnea (HP:0002870) | 2.38485762 |
83 | Respiratory failure (HP:0002878) | 2.37944119 |
84 | Cervical subluxation (HP:0003308) | 2.36516907 |
85 | Lactic acidosis (HP:0003128) | 2.36125915 |
86 | Oligomenorrhea (HP:0000876) | 2.35411023 |
87 | Congenital glaucoma (HP:0001087) | 2.34991051 |
88 | Myopathic facies (HP:0002058) | 2.34832399 |
89 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.33303197 |
90 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.32739677 |
91 | Acanthosis nigricans (HP:0000956) | 2.31983277 |
92 | Type 1 muscle fiber predominance (HP:0003803) | 2.31947183 |
93 | Supranuclear gaze palsy (HP:0000605) | 2.31743005 |
94 | Hamartoma of the eye (HP:0010568) | 2.31657729 |
95 | Buphthalmos (HP:0000557) | 2.30459152 |
96 | Hypercortisolism (HP:0001578) | 2.29593005 |
97 | Neuroendocrine neoplasm (HP:0100634) | 2.27988766 |
98 | Ketosis (HP:0001946) | 2.26911391 |
99 | Muscle fiber inclusion bodies (HP:0100299) | 2.26847573 |
100 | Stridor (HP:0010307) | 2.26843498 |
101 | Bladder diverticulum (HP:0000015) | 2.26756520 |
102 | Cerebral inclusion bodies (HP:0100314) | 2.25263533 |
103 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.24940146 |
104 | Bulbar palsy (HP:0001283) | 2.23416047 |
105 | Mitral regurgitation (HP:0001653) | 2.22584357 |
106 | Distal lower limb amyotrophy (HP:0008944) | 2.21989445 |
107 | Limb-girdle muscle atrophy (HP:0003797) | 2.20147466 |
108 | Palmoplantar keratoderma (HP:0000982) | 2.19836409 |
109 | Esophageal neoplasm (HP:0100751) | 2.19313927 |
110 | Neoplasm of head and neck (HP:0012288) | 2.19313927 |
111 | Slender build (HP:0001533) | 2.18989412 |
112 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.18492877 |
113 | Neoplasm of the adrenal gland (HP:0100631) | 2.18128095 |
114 | Fragile skin (HP:0001030) | 2.17687594 |
115 | Joint stiffness (HP:0001387) | 2.17660033 |
116 | Hyperparathyroidism (HP:0000843) | 2.17380386 |
117 | Abnormality of the Achilles tendon (HP:0005109) | 2.15452585 |
118 | Distal lower limb muscle weakness (HP:0009053) | 2.13076217 |
119 | Ulnar deviation of the wrist (HP:0003049) | 2.12097335 |
120 | Upper limb amyotrophy (HP:0009129) | 2.12067116 |
121 | Distal upper limb amyotrophy (HP:0007149) | 2.12067116 |
122 | Nemaline bodies (HP:0003798) | 2.10028087 |
123 | Athetosis (HP:0002305) | 2.09413545 |
124 | J-shaped sella turcica (HP:0002680) | 2.09077323 |
125 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.07837644 |
126 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.07837644 |
127 | Large for gestational age (HP:0001520) | 2.07431505 |
128 | Neck muscle weakness (HP:0000467) | 2.06217508 |
129 | Hyperacusis (HP:0010780) | 2.04822599 |
130 | Aortic aneurysm (HP:0004942) | 2.04432595 |
131 | Hypertriglyceridemia (HP:0002155) | 2.04248419 |
132 | Foot dorsiflexor weakness (HP:0009027) | 2.04097621 |
133 | Blue sclerae (HP:0000592) | 2.03693887 |
134 | Wormian bones (HP:0002645) | 2.03018962 |
135 | Turricephaly (HP:0000262) | 2.02984922 |
136 | Ankle contracture (HP:0006466) | 2.01759010 |
137 | Dysmetric saccades (HP:0000641) | 1.99791261 |
138 | Abnormality of complement system (HP:0005339) | 1.99108555 |
139 | Vascular tortuosity (HP:0004948) | 1.99023314 |
140 | Areflexia of lower limbs (HP:0002522) | 1.98810710 |
141 | Complement deficiency (HP:0004431) | 1.98540490 |
142 | Increased cerebral lipofuscin (HP:0011813) | 1.95564190 |
143 | Mesangial abnormality (HP:0001966) | 1.95411158 |
144 | EMG: neuropathic changes (HP:0003445) | 1.91744725 |
145 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.88931087 |
146 | Lymphangioma (HP:0100764) | 1.88171718 |
147 | Sudden cardiac death (HP:0001645) | 1.86885330 |
148 | Emphysema (HP:0002097) | 1.86786847 |
149 | Multiple enchondromatosis (HP:0005701) | 1.86460381 |
150 | Abnormality of alanine metabolism (HP:0010916) | 1.86429098 |
151 | Hyperalaninemia (HP:0003348) | 1.86429098 |
152 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86429098 |
153 | Biconcave vertebral bodies (HP:0004586) | 1.85150236 |
154 | Progressive muscle weakness (HP:0003323) | 1.83980200 |
155 | Hyperglycinuria (HP:0003108) | 1.83163765 |
156 | Loss of speech (HP:0002371) | 1.82419335 |
157 | Growth hormone excess (HP:0000845) | 1.81848545 |
158 | Tinnitus (HP:0000360) | 1.81523777 |
159 | Generalized aminoaciduria (HP:0002909) | 1.80986844 |
160 | Glomerulonephritis (HP:0000099) | 1.79461719 |
161 | Lipid accumulation in hepatocytes (HP:0006561) | 1.78579896 |
162 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.78264043 |
163 | Generalized muscle weakness (HP:0003324) | 1.78211607 |
164 | Distal arthrogryposis (HP:0005684) | 1.77896404 |
165 | Venous abnormality (HP:0002624) | 1.77676610 |
166 | Congestive heart failure (HP:0001635) | 1.77593354 |
167 | Hyperthyroidism (HP:0000836) | 1.76467593 |
168 | Abnormality of the foot musculature (HP:0001436) | 1.75690128 |
169 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73794643 |
170 | Broad metatarsal (HP:0001783) | 1.71909692 |
171 | Hypercalcemia (HP:0003072) | 1.71283002 |
172 | Diaphragmatic weakness (HP:0009113) | 1.70157512 |
173 | Generalized amyotrophy (HP:0003700) | 1.69810855 |
174 | Genu recurvatum (HP:0002816) | 1.68185332 |
175 | Xanthomatosis (HP:0000991) | 1.67839294 |
176 | Skin nodule (HP:0200036) | 1.66605922 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 5.08320511 |
2 | TRIB3 | 4.04352139 |
3 | PHKG2 | 3.84689849 |
4 | PHKG1 | 3.84689849 |
5 | LMTK2 | 3.72390841 |
6 | PKN2 | 3.62529870 |
7 | PDK3 | 3.10961875 |
8 | PDK4 | 3.10961875 |
9 | MYLK | 3.05981382 |
10 | OBSCN | 3.02705299 |
11 | BCKDK | 2.99228391 |
12 | DMPK | 2.68537852 |
13 | NEK1 | 2.48467062 |
14 | PINK1 | 2.44471277 |
15 | TESK1 | 2.20619180 |
16 | PRPF4B | 2.19091921 |
17 | IRAK3 | 2.13265074 |
18 | ARAF | 2.04045283 |
19 | PDK2 | 1.66492404 |
20 | PRKD3 | 1.65052293 |
21 | LIMK1 | 1.62207638 |
22 | ILK | 1.51283440 |
23 | MUSK | 1.50265564 |
24 | PIM2 | 1.50220185 |
25 | ABL2 | 1.48193645 |
26 | PIK3CA | 1.47363349 |
27 | WNK4 | 1.44353055 |
28 | MOS | 1.43674063 |
29 | TGFBR2 | 1.35108630 |
30 | ICK | 1.34151008 |
31 | TAOK2 | 1.33840746 |
32 | MAP3K13 | 1.28384252 |
33 | EEF2K | 1.28297318 |
34 | RIPK1 | 1.28280817 |
35 | STK24 | 1.24629018 |
36 | PAK3 | 1.23676196 |
37 | PRKD1 | 1.22397361 |
38 | CDC42BPA | 1.18724064 |
39 | PDGFRA | 1.17817916 |
40 | TIE1 | 1.15350908 |
41 | MARK2 | 1.12946251 |
42 | SMG1 | 1.12920113 |
43 | NME2 | 1.10774555 |
44 | DAPK3 | 1.06518677 |
45 | MAP3K7 | 1.05496294 |
46 | CAMK2D | 1.04384297 |
47 | LATS2 | 1.04148660 |
48 | STK38 | 1.04073171 |
49 | PTK2 | 1.03972206 |
50 | MAP3K10 | 1.03447504 |
51 | GRK7 | 1.02738126 |
52 | TBK1 | 0.98342841 |
53 | EPHB1 | 0.93284050 |
54 | PRKAA1 | 0.92832393 |
55 | ROCK1 | 0.88688780 |
56 | CAMK4 | 0.88603602 |
57 | MAPK12 | 0.87916198 |
58 | NTRK1 | 0.85946870 |
59 | BRAF | 0.85591057 |
60 | MARK3 | 0.83008151 |
61 | RPS6KC1 | 0.82261762 |
62 | RPS6KL1 | 0.82261762 |
63 | FLT3 | 0.81154345 |
64 | HIPK2 | 0.80613060 |
65 | UHMK1 | 0.80343503 |
66 | FGFR4 | 0.77740897 |
67 | MAPK7 | 0.77170625 |
68 | ERN1 | 0.75502277 |
69 | MAPK4 | 0.75453091 |
70 | SIK1 | 0.73308360 |
71 | WNK1 | 0.72835206 |
72 | PRKAA2 | 0.71260361 |
73 | RPS6KA6 | 0.70363319 |
74 | CAMK1 | 0.65860092 |
75 | PAK2 | 0.62608073 |
76 | MAP3K11 | 0.62591240 |
77 | RIPK4 | 0.61626492 |
78 | PAK6 | 0.60911475 |
79 | MAPKAPK3 | 0.60426294 |
80 | STK38L | 0.60392413 |
81 | PAK4 | 0.60309077 |
82 | IRAK2 | 0.60126514 |
83 | CAMK2B | 0.59714160 |
84 | CAMK1D | 0.58743972 |
85 | MAP2K3 | 0.57903609 |
86 | PRKD2 | 0.57178823 |
87 | SIK2 | 0.55854796 |
88 | MAP2K6 | 0.55601550 |
89 | AKT2 | 0.55079357 |
90 | EPHB2 | 0.53842461 |
91 | MAP2K2 | 0.53272333 |
92 | ROCK2 | 0.52420925 |
93 | MARK1 | 0.52287312 |
94 | MAP3K5 | 0.51902498 |
95 | CAMK1G | 0.51681466 |
96 | CAMK2A | 0.50885855 |
97 | NME1 | 0.50256733 |
98 | PRKCH | 0.49199255 |
99 | DYRK1B | 0.49011942 |
100 | TNK2 | 0.48998448 |
101 | NEK9 | 0.48556951 |
102 | TAOK1 | 0.48121358 |
103 | BMX | 0.48081218 |
104 | KSR2 | 0.47744089 |
105 | DDR2 | 0.47286353 |
106 | GSK3A | 0.47211019 |
107 | PTK2B | 0.46781020 |
108 | PDPK1 | 0.46342685 |
109 | RPS6KA1 | 0.45639468 |
110 | PRKACG | 0.44906927 |
111 | MAP2K4 | 0.44834135 |
112 | TYK2 | 0.44439381 |
113 | LRRK2 | 0.43175752 |
114 | GRK5 | 0.43114953 |
115 | MAP3K9 | 0.42005194 |
116 | PDGFRB | 0.41777728 |
117 | RET | 0.40648213 |
118 | STK4 | 0.39490630 |
119 | MTOR | 0.38920811 |
120 | PRKACB | 0.38391289 |
121 | PRKG2 | 0.37976655 |
122 | PRKACA | 0.37745236 |
123 | RPS6KA2 | 0.37316755 |
124 | MAP3K6 | 0.34357134 |
125 | PDK1 | 0.32190459 |
126 | CAMKK1 | 0.31914653 |
127 | MAP3K4 | 0.31409628 |
128 | CAMK2G | 0.31154622 |
129 | PTK6 | 0.29056259 |
130 | TYRO3 | 0.28309792 |
131 | MAP3K1 | 0.27768284 |
132 | RPS6KA3 | 0.26180013 |
133 | MAPK11 | 0.25932020 |
134 | TRPM7 | 0.25118619 |
135 | KDR | 0.24388864 |
136 | PRKCE | 0.22547820 |
137 | ALK | 0.22365201 |
138 | MAP3K3 | 0.22098814 |
139 | NTRK3 | 0.21210993 |
140 | SGK1 | 0.20055664 |
141 | PKN1 | 0.17714120 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.92284463 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.43150489 |
3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.05567262 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.50286676 |
5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.41692513 |
6 | Other glycan degradation_Homo sapiens_hsa00511 | 3.23956318 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.15836795 |
8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.94829369 |
9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.72268769 |
10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.69142573 |
11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62329538 |
12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.57272370 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51896613 |
14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.50041404 |
15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.34503207 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22734372 |
17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.20306945 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.14840990 |
19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.07467282 |
20 | Lysosome_Homo sapiens_hsa04142 | 2.06908923 |
21 | Prion diseases_Homo sapiens_hsa05020 | 1.89125280 |
22 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.88690487 |
23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.78342356 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70588039 |
25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.58422736 |
26 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.47463813 |
27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.36259737 |
28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.33574599 |
29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27118944 |
30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.21959471 |
31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15232026 |
32 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.15210082 |
33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13512642 |
34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.11534374 |
35 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11374114 |
36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08006754 |
37 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.07398703 |
38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.05983074 |
39 | Bladder cancer_Homo sapiens_hsa05219 | 1.01265716 |
40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99934005 |
41 | Insulin resistance_Homo sapiens_hsa04931 | 0.97089045 |
42 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95213476 |
43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93755710 |
44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90306070 |
45 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.86518296 |
46 | Amoebiasis_Homo sapiens_hsa05146 | 0.83614877 |
47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83072236 |
48 | Malaria_Homo sapiens_hsa05144 | 0.81901162 |
49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81427736 |
50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81080271 |
51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80955040 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80518558 |
53 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80266059 |
54 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79816962 |
55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78829405 |
56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78564049 |
57 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77716492 |
58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76620119 |
59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76168563 |
60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75423893 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 0.75126451 |
62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74144754 |
63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73374525 |
64 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71447118 |
65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71408633 |
66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70307679 |
67 | Phagosome_Homo sapiens_hsa04145 | 0.68761394 |
68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68149045 |
69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67924141 |
70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67854537 |
71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67593261 |
72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65147899 |
73 | Insulin secretion_Homo sapiens_hsa04911 | 0.64545279 |
74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62097314 |
75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61535071 |
76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61468886 |
77 | Pertussis_Homo sapiens_hsa05133 | 0.61465248 |
78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59726826 |
79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59650895 |
80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58994408 |
81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57049237 |
82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56554346 |
83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56476530 |
84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55840857 |
85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53959400 |
86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53525191 |
87 | Endocytosis_Homo sapiens_hsa04144 | 0.53474354 |
88 | Renin secretion_Homo sapiens_hsa04924 | 0.53355536 |
89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52344303 |
90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51437954 |
91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50635836 |
92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50392330 |
93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50337976 |
94 | Salmonella infection_Homo sapiens_hsa05132 | 0.49246013 |
95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49147599 |
96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47786817 |
97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47508491 |
98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47471982 |
99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46674121 |
100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46423391 |
101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46210208 |
102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46148006 |
103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45467866 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45407174 |
105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45358344 |
106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45265769 |
107 | * Focal adhesion_Homo sapiens_hsa04510 | 0.44336464 |
108 | Gap junction_Homo sapiens_hsa04540 | 0.43951111 |
109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43008984 |
110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42077590 |
111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41974452 |
112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36803124 |
113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35934352 |
114 | Peroxisome_Homo sapiens_hsa04146 | 0.35518117 |
115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35508741 |
116 | Tight junction_Homo sapiens_hsa04530 | 0.35042973 |
117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31923208 |
118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.29877311 |
119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29349414 |
120 | Salivary secretion_Homo sapiens_hsa04970 | 0.28065646 |
121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27808839 |
122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27743066 |
123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26507689 |
124 | Taste transduction_Homo sapiens_hsa04742 | 0.25728202 |
125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24048506 |
126 | Melanogenesis_Homo sapiens_hsa04916 | 0.23505804 |
127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23189032 |
128 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21449418 |
129 | Morphine addiction_Homo sapiens_hsa05032 | 0.20135222 |
130 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19997018 |
131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18884749 |
132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18378563 |
133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.17860507 |
134 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17616842 |
135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.17116244 |
136 | Glioma_Homo sapiens_hsa05214 | 0.16764975 |
137 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.16757799 |
138 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.16721596 |
139 | Adherens junction_Homo sapiens_hsa04520 | 0.15616698 |
140 | Bile secretion_Homo sapiens_hsa04976 | 0.14878134 |
141 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.14557569 |
142 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.14125551 |
143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.13530440 |
144 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.12050031 |